Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Flonase, Zaditor DTC Ads Cited By FDA; Both Allergy Campaigns Are Over

Executive Summary

FDA is directing GlaxoSmithKline and Novartis to revise direct-to-consumer ads for allergy products attempting to capitalize on the changes in the market following the OTC switch of Claritin

Related Content

FDA Invites Manufacturers, Ad Agencies To Discuss DTC Ad Designs
DTC Comparative Drug Campaigns To Be Addressed At FDA Public Meeting
Generic Omeprazole Ads Debut; Schwarz Offers $10 Rebate For Copays
Allegra DTC Ads Include Comparative Claims Against Zyrtec, OTCs
DTC Battle: PhRMA Should Pay More Attention To Issue, Sen. Craig Says
Berlex Yasmin TV Ad Cited By FDA Following Release In Test Markets
Websites Must Be Submitted To FDA Like Other Ads, Agency Reminds Industry
Flonase DTC Ads Highlight Formulary Status Versus Antihistamines
Flonase DTC Ads Highlight Formulary Status Versus Antihistamines
DTC Ad Letter Review Cited By GAO; Chief Counsel’s Office Adds Two To Task



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts